XML 64 R53.htm IDEA: XBRL DOCUMENT v3.19.2
Stock Based Compensation (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of shares authorized 3,000,000      
Weighted Average Grant Date Fair Value of Restricted Stock        
Employee Service Share-based Compensation, Tax Benefit from Compensation Expense     $ 95,000 $ 20,000
Shares Paid for Tax Withholding for Share Based Compensation     7,744 17,180
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $ 0      
Restricted Stock [Member]        
Restricted Stock Rollforward, Shares        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number     349,885  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period     132,327  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period     86,316  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period     10,580  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 385,316   385,316  
Weighted Average Grant Date Fair Value of Restricted Stock        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value     $ 10.62  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value     7.69  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value     13.97  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value     15.06  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $ 9.92   $ 9.92  
Unrecognized compensation expense $ 2,736,000 $ 2,957,000   $ 2,957,000
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term     1 year 7 months  
Restricted Stock [Member] | Selling, General and Administrative Expenses [Member]        
Weighted Average Grant Date Fair Value of Restricted Stock        
Compensation costs 413,000 639,000 $ 763,000 970,000
Stock Appreciation Rights (SARs) [Member]        
Weighted Average Grant Date Fair Value of Restricted Stock        
Unrecognized compensation expense $ 478,000 0   0
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term 2 years 10 months      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number     0  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross     226,021  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period     0  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares     0  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 226,021   226,021  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 29,028      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price     $ 0.00  
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price     2.57  
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price     0.00  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price     0.00  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $ 2.57   $ 2.57  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value     $ 2.57  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term     4 years 10 months  
Class of Warrant or Right, Exercise Price of Warrants or Rights $ 10   $ 0.00  
Stock Appreciation Rights (SARs) [Member] | Selling, General and Administrative Expenses [Member]        
Weighted Average Grant Date Fair Value of Restricted Stock        
Compensation costs     $ 103,000 0
Foreign Exchange Forward [Member] | Cost of Sales [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net $ (79,000) 50,000 (55,000) 196,000
Foreign Exchange Forward [Member] | Selling, General and Administrative Expenses [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net (4,000) 7,000 8,000 29,000
Interest Rate Swap [Member] | Interest Expense [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net $ (1,000) $ (50,000) $ 0 $ (108,000)